Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Daiichi Sankyo
Farmers Insurance
Colorcon
Cantor Fitzgerald

Generated: July 16, 2019

DrugPatentWatch Database Preview

Natalizumab - Biologic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for natalizumab
Tradenames:1
Patents:156
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for natalizumab
Pharmacology for natalizumab
Mechanism of ActionIntegrin Receptor Antagonists

US Patents for natalizumab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Pathologica LLC (San Francisco, CA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial CureVac AG (Tubingen, DE) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Biogen MA Inc. (Cambridge, MA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial BIOGEN MA INC. (Cambridge, MA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Population Bio, Inc. (New York, NY) The Universite Paris-Sud (FR) The Assistance Publique--Hopitaux de Paris (APHP) (FR) The Institut National de la Sante et de la Recherche Medicale (INSERM) (FR) PML Screening, LLC (Newport Beach, CA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial CytomX Therapeutics, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for natalizumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB06/025 United Kingdom ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB, ANTI -4 INTEGRIN HUMANIZED MONOCLONAL ANTIBODY; REGISTERED: UK EU/1/06/346/001 20060627
0967 Netherlands ➤ Try a Free Trial PRODUCT NAME: TISAGENLECLEUCEL; REGISTRATION NO/DATE: EU/1/18/1297 20180827
0240 Netherlands ➤ Try a Free Trial PRODUCT: NATALIZUMAB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; FIRST REGISTRATION, DATE: EU/1/06/346/001, 20060627
00238 Netherlands ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB; REGISTRATION NO/DATE: EU/1/06/346/001 20060627
2006 00023 Denmark ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB
2019000007 Germany ➤ Try a Free Trial PRODUCT NAME: TISAGENLECLEUCEL; REGISTRATION NO/DATE: EU/1/18/1297 20180823
06/025 Ireland ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB (ALSO KNOWN AS TYSABRI); REGISTRATION NO/DATE: EU/1/06/346/001 20060627
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Harvard Business School
Chinese Patent Office
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.